ReviewEvolutionary applications2026
Systematic Review on the Association Between Sleep and the Risk of Alzheimer's Disease: An Evolutionary Perspective.
Review in Evolutionary applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) is an important, non-curable disease today. Several possible risk factors have been discussed, among others sleep. Evolutionary hypotheses were proposed to explain sleep variation and AD risk, such as a potential advantage of short or interrupted sleep in ancient insecure environments, the evolution of increased plasticity of the human brain, or antagonistic pleiotropy with increased AD risk. The aim of this systematic review was to investigate in which way sleep is associated with AD risk, in the light of evolutionary hypotheses. Following PRISMA guidelines, the databases PubMed and Embase were searched for longitudinal observational studies on the association between sleep and incident AD in cognitively healthy people at baseline. Potential confounders were assessed (e.g., age, sex, country, etc.). Search results were deduplicated and assessed for inclusion or exclusion by two independent reviewers. We summarized the results in tables and performed meta-analyses in risk factor subgroups where appropriate. Out of 5800 studies, 39 were suitable for this review and 35 were meta-analyzed. Long sleep duration showed a positive association with AD (HR = 1.35, 95% CI = 1.12-1.63) that was not significant after accounting for heterogeneity using prediction intervals (95% CI = 0.74-2.49). Short sleep duration showed a weak, non-significant association with AD risk (HR = 1.07, 95% CI = 0.98-1.18). Several measures of sleep quality (hypnotics use, daytime sleepiness, bad overall sleep quality, and early bedtime) showed an increased risk for AD, while others (e.g., late bedtime) showed a protective effect. This systematic review showed possible associations between sleep characteristics and the risk for AD. However, several results showed heterogeneity that we could not explain with the information given in the publications. More work is therefore needed to assess the risk factors for AD connected to sleep.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.